Business Context and Reporting Period
Company: Ultralife Batteries, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 29, 2003
Business Overview: The company develops, manufactures, and markets lithium primary (non-rechargeable) and rechargeable batteries for military, industrial, and consumer applications. Effective December 31, 2002, the company changed its fiscal year-end from June 30 to December 31.
Key Financial Metrics
| Metric (in thousands) | Q1 2003 | Q1 2002 |
|---|---|---|
| Revenues | $15,428 | $8,862 |
| Gross Margin | $3,159 (20.5%) | $922 (10.4%) |
| Operating Income | $612 | $(2,097) |
| Net Income | $311 | $(2,793) |
| Earnings Per Share (Basic) | $0.02 | $(0.23) |
| Cash and Equivalents | $394 | $344 |
| Short-term Debt | $1,439 | $816 |
| Long-term Debt | $1,154 | $1,354 |
| Net Cash Used in Operating Activities | $(62) | $(2,506) |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 74% to $15.4 million, driven primarily by a 67% increase in Primary Battery sales ($14.6 million) due to strong military shipments (UBI5390) and a record order from the U.K. Ministry of Defence for 9-volt batteries.
- Profitability: The company achieved its first-ever operating profitability ($612k) and net income ($311k), reversing a net loss of $2.8 million in the prior year. This was driven by improved gross margins (20.5% vs 10.4%) and reduced operating expenses.
- Operating Expenses: Total operating expenses decreased 16% to $2.5 million, largely due to a $453k reduction in R&D costs and lower depreciation.
- Working Capital: Accounts receivable increased significantly ($3.5 million usage) due to higher sales volume, though Days Sales Outstanding (DSO) improved to 51 days from 63 days.
- Capital Expenditures: Investing cash outflows increased to $1.4 million (from $2.3 million inflow in 2002) due to purchases of plant and equipment to expand production capacity.
Guidance, Outlook, and Risks
Management Outlook
- Revenue Guidance: Full-year 2003 revenue is projected to be at least $65 million (up from previous guidance of $50 million). Q2 2003 revenue is expected to reach approximately $18 million.
- Earnings Guidance: Basic EPS for Q2 2003 is projected between $0.11 and $0.15. Full-year 2003 basic EPS is projected between $0.35 and $0.45.
- Capital Needs: Capital expenditures for 2003 are expected to range from $3 million to $4 million. Management believes operations can be financed through internal funds and existing credit facilities over the next 12 months.
Risks and Contingencies
- Legal Proceedings: A shareholder class action lawsuit regarding a 1998 offering is in settlement negotiations for $175,000. The company's insurance carrier is in liquidation and may not fund the settlement.
- Environmental Liability: Contaminated soil and groundwater were found at the Newark, NY facility. Estimated remediation costs are $230,000 (50% reimbursable by a third party), though final costs are uncertain.
- Grant/Loan Conditions: A $750,000 government grant/loan requires meeting specific employment levels for three years; failure to do so converts the grant to a repayable loan.
- Customer Claims: A potential product defect claim exists regarding a customer's product powered by Ultralife batteries; no claim has been filed against Ultralife yet, but technical support is being provided.
Investor Verification Checklist
- Verify the sustainability of military demand for the UBI5390 battery, which drove the majority of Q1 revenue growth.
- Confirm the status of the $175,000 shareholder lawsuit settlement and the likelihood of insurance coverage denial.
- Monitor the final cost of environmental remediation at the Newark facility against the current $230,000 estimate.
- Assess the company's ability to maintain employment levels required to keep the $750,000 government grant from converting to debt.
- Review the company's cash burn rate relative to its $3.5 million remaining revolver capacity and upcoming $500,000 convertible note maturity in June 2003.